PERITI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.458
AS - Asia 4.270
EU - Europa 3.688
SA - Sud America 499
OC - Oceania 111
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.114
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.395
RU - Federazione Russa 1.700
CN - Cina 1.241
SG - Singapore 1.157
HK - Hong Kong 563
KR - Corea 519
IE - Irlanda 493
BR - Brasile 404
VN - Vietnam 370
SE - Svezia 316
UA - Ucraina 259
DE - Germania 246
IT - Italia 194
FI - Finlandia 165
IN - India 156
FR - Francia 150
AU - Australia 108
GB - Regno Unito 90
JP - Giappone 72
TR - Turchia 42
JO - Giordania 37
AR - Argentina 36
CA - Canada 32
NG - Nigeria 25
BD - Bangladesh 19
MX - Messico 19
PE - Perù 16
ES - Italia 15
ZA - Sudafrica 15
IQ - Iraq 14
EC - Ecuador 13
NL - Olanda 12
PL - Polonia 12
CI - Costa d'Avorio 10
PK - Pakistan 10
BJ - Benin 9
ID - Indonesia 9
SC - Seychelles 9
UZ - Uzbekistan 9
UY - Uruguay 8
VE - Venezuela 8
CH - Svizzera 7
TW - Taiwan 7
CL - Cile 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CO - Colombia 5
MA - Marocco 5
AZ - Azerbaigian 4
CR - Costa Rica 4
DK - Danimarca 4
OM - Oman 4
AL - Albania 3
BE - Belgio 3
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PY - Paraguay 3
TH - Thailandia 3
AM - Armenia 2
AT - Austria 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
NP - Nepal 2
PH - Filippine 2
AP - ???statistics.table.value.countryCode.AP??? 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VG - Isole Vergini Britanniche 1
Totale 15.114
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.713
Singapore 830
Seoul 502
Dublin 492
Hefei 488
Chandler 476
Jacksonville 471
Hong Kong 440
Ashburn 395
Fairfield 353
San Jose 188
Cambridge 157
Woodbridge 146
The Dalles 140
Ho Chi Minh City 139
Buffalo 129
Los Angeles 127
Seattle 125
Wilmington 125
Houston 118
Lauterbourg 118
Beijing 115
Melbourne 99
Mumbai 92
Hanoi 90
Princeton 86
Boardman 78
Tokyo 70
Boston 65
Helsinki 55
Kent 53
Lawrence 51
New York 50
Moscow 47
Dallas 45
Medford 45
Ann Arbor 43
Munich 42
Altamura 41
Shanghai 40
São Paulo 36
Milan 35
San Diego 23
Bengaluru 22
Abuja 21
Turku 19
Norwalk 18
West Jordan 18
Auburn Hills 17
Guangzhou 17
Pune 17
Tianjin 17
Haiphong 15
Orem 15
Da Nang 14
Hillsboro 14
Frankfurt am Main 12
Izmir 12
Lima 12
Chennai 11
Paris 11
Abidjan 10
Andover 9
Brasília 9
Brooklyn 9
Cotonou 9
Florence 9
Montreal 9
Warsaw 9
Baghdad 8
Biên Hòa 8
Dearborn 8
Frankfurt Am Main 8
London 8
Barnet 7
Denver 7
Dhaka 7
Phoenix 7
Redondo Beach 7
Redwood City 7
Rio de Janeiro 7
Tashkent 7
Toronto 7
Yubileyny 7
Belo Horizonte 6
Bern 6
Charlotte 6
Council Bluffs 6
Iksan 6
Johannesburg 6
Manchester 6
Porto Alegre 6
Volta Redonda 6
Atlanta 5
Curitiba 5
Dong Nai 5
Guarulhos 5
Guayaquil 5
Montevideo 5
Recife 5
Totale 9.527
Salva come PNG Salva come JPEG
Nome #
[Medical therapy of malignant melanoma] 238
Bacillus subtilis spores as a natural pro-host oral agent. Preliminary data in children. 173
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 164
Adverse effects of macrolide antibacterials. 159
In vitro brodimoprim activity on nosocomial bacterial strains. 158
[Plasma and tissue antibiotic concentrations: what is their prognostic value?] 156
Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. 156
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro 154
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI) 152
Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin 151
Phase I clinical trial of a new alkylating agent, PTT-119 148
[Antibiotic prophylaxis of postoperative infection in orthopedics. Results of an epidemiologic survey in Italy conducted by the Journal of Chemotherapy] 148
Pharmacokinetics and endocrine effects of leuprolide depot in advanced prostatic cancer: a dose-response analysis 147
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 147
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or with levamisole (LEV) or interferon alpha2a (IFN alpha2a). 146
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 144
Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery. 144
Ofloxacin concentrations in human inflamed pericoronal tissue after oral administration. 143
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 141
Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial. 140
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI) 139
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 139
Comparative in vitro activity of ciprofloxacin against methicillin-resistant staphylococci 138
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 137
Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. 136
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 136
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies. 135
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 134
Pharmacokinetics of oral medroxyprogesterone acetate at moderate doses. 133
Phase II study of 5-FU plus 6-S-leucovorin (6S-LV) in advanced colorectal cancer 132
Phase I trial of a novel alkylating agent 132
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma. 132
PHASE II TRIAL OF 5-FLUOROURACIL AND THE NATURAL L-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL CARCINOMA. 131
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM 130
Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU) 129
Effects of 5-methyltetrahydrofolate on the activity of fluoropyrimidines against human leukemia (CCRF-CEM) cells. 129
Human pharmacokinetic and pharmacodynamic profiles of leuprorelin acetate depot in prostatic cancer patients. 129
Ciprofloxacin inhibition of cefoxitin betalactamase induction in an Enterobacter cloacae strain. 129
Preliminary results of a phase II multicenter study on the clinical efficacy and safety to the LH-RH analog leuprolide in the treatment of prostatic carcinoma 128
Clinical pharmacokinetics of depot leuprorelin. 128
Pharmacokinetics and blister fluid penetration of brodimoprim in adults. 128
A randomized multicenter study comparing 5-fluorouracil (5-FU) and l-folinic acid (L-LV) alone or with levamisole (LEV) or interferon alpha2a (IFNalpha2a) as adjuvant therapy for colorectal cancer 128
Penetration of cefotetan into suction skin blister fluid and tissue homogenates in patients undergoing abdominal surgery. 127
Beta-lactamase evaluation of the amoxycillin-clavulanate association. 126
Oral medroxyprogesterone acetate pharmacokinetics: results in a group of patients during a controlled clinical trial on stage I endometrial carcinoma. 125
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery. 124
Pharmacokinetics of roxithromycin in renal and hepatic failure and drug interactions. 124
Moxalactam pharmacokinetics in healthy volunteers and patients with renal insufficiency. 123
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 123
Chemoresistance to fosfomycin: a bacteriological study. 122
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 121
Perioperative chemotherapy in thet reatment of carcinoma of the uterine cervix 121
Clinical pharmacokinetics of cefpodoxime proxetil in older patients 120
Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. 120
Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study. 119
First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer. 119
High dose fosfomycin: indications, tolerance and pharmacokinetics. 119
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin 118
Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells 118
Comparative in vitro evaluation of the antimicrobial activity of flurithromycin by means of the MS-2 Abbott Research System. 118
Tissue distribution of antimicrobial drugs. 118
A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion 118
New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock. 117
In vitro effects of brodimoprim on human polymorphonuclear leukocyte functions. Preliminary results 116
Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. 116
Prophylactic chemotherapy with fosfomycin trometamol salt during transurethral prostatic surgery: a controlled multicenter clinical trial. 116
Tissue distribution of cefotetan in patients with Crohn's disease. 115
The suction blister technique as a tool in antimicrobial drug pharmacokinetics. 115
Selecting antibacterial agents for the control of surgical infection: mini-review. 113
Drug resistance in cancer: an overview of the clinical aspects. 112
Teicoplanin: its role as systemic burn therapy and as prophylaxis for orthopedic surgery 111
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 111
Impaired methotrexate polyglutamylation in a human leukemia cell line resistant to short-term, high-dose methotrexate. 111
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano. 107
Fluoropyrimidine-folate synergy in human leukemia-lymphoma cells in culture 105
Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin 103
Ceftizoxime concentrations in human aqueous humor following intravenous administration. 103
Clinical pharmacokinetics and tissue penetration of teicoplanin 101
Pharmacokinetics and endocrine effects of leuprolide depot 101
Flow cytometric analysis of DNA ploidy and cell proliferation activity in colorectal carcinoma. 101
Cisplatin and etoposide combination in the treatment of bronchogenic carcinoma 98
Single-dose ceftriaxone versus multi-dose cefotaxime as short-term antimicrobial prophylaxis in urologic surgery. Preliminary results of a multicenter prospective randomized study 97
Clinical pharmacokinetics of enoxacin in subjects with renal or hepatic impairment. 97
Impaired polyglutamylation of methotrexate as a cause of resistance in CCRF-CEM cells after short-term, high-dose treatment with this drug. 97
Single-dose ceftriaxone versus multi-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter prospective randomized study 95
Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic joint implant surgery. Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery. 95
Phase I study of LY186641, a diarylsulfonylurea given on alternative weeks to patients with solid tumours 94
Single-dose cefotetan vs. multiple-dose cefoxitin--antimicrobial prophylaxis in colorectal surgery. Results of a prospective, multicenter, randomized study. 94
Single-dose ceftriaxone vs. multiple-dose cefotaxime antimicrobial prophylaxis in gynecologic and obstetrical surgery. Preliminary results of a multicenter propsective randomized study 94
Infections in immunocompromised patients. II. Established therapy and its limitations. 93
Sviluppo di linee cellulari leu¬cemiche umane resistenti al metotres¬sato (MTX). Ri¬sultati preliminari con un modello in studio in vitro alternativo 93
Concentration-effect relationship for antimicrobial drugs. 92
Clinical pharmacokinetics and tissue penetration of teicoplanin. 92
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections 92
Efficacy and safety of once-daily versus twice-daily administration of netilmicin in patients with urinary tract infections. 92
Clarithromycin: pharmacokinetics and pharmacodynamics 92
Mitoxantrone (dihydro-anthracenedione, DHAD) combined with cyclophosphamide (CYC) as first line chemotherapy in advanced breast cancer 91
Penicilline, cefalosporine e altre beta-lattamine. 91
Microbiological and pharmacokinetic evaluation of cefonicid 90
Pharmacokinetics of azithromycin in patients with impaired hepatic function. 90
Totale 12.287
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.199
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.199
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/2022471 8 61 4 39 13 15 5 38 22 8 135 123
2022/20231.783 136 159 33 182 192 401 279 111 204 10 50 26
2023/2024689 44 81 147 32 55 121 10 149 4 22 10 14
2024/20254.992 183 543 254 704 1.362 746 60 215 298 117 220 290
2025/20264.826 666 962 760 539 439 134 545 223 289 162 85 22
Totale 15.177